Related Experiment Videos
Transferrin C2, metal binding and Alzheimer's disease
G F Van Landeghem1, C Sikström, L E Beckman
1Department of Medical Genetics, Umeå University, Sweden.
Neuroreport
|March 21, 1998
Summary
The transferrin C2 variant (TFC2) is associated with Alzheimer's disease (AD). However, TFC2 did not show differences in binding iron or aluminum compared to other transferrin variants.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- The transferrin (TF) variant C2 has been linked to disorders potentially caused by oxygen free radicals.
- An increased frequency of the TFC2 variant has been observed in Alzheimer's disease (AD) patients.
- It is hypothesized that AD may result from free radical damage due to impaired iron and aluminum binding by TFC2.
Purpose of the Study:
- To investigate the association between the TFC2 variant and Alzheimer's disease (AD).
- To examine the binding capacity of iron and aluminum by TFC2 compared to other TF variants in AD patients.
Main Methods:
- A study was conducted on 64 patients diagnosed with Alzheimer's disease from northern Sweden.
- The frequency of the TFC2 variant was analyzed in the patient cohort.
- Binding affinities of iron and aluminum were compared between TFC2 and other TF variants.
Main Results:
- The study confirmed a significant association between the TFC2 variant and Alzheimer's disease (AD).
- No significant differences were found in the binding of iron and aluminum between TFC2 and other TF variants.
Conclusions:
- The association between TFC2 and AD is confirmed, supporting a potential genetic link.
- The hypothesis that TFC2's role in AD is due to defective iron and aluminum binding is not supported by this study.
- Further research is needed to elucidate the exact mechanisms linking TFC2 to Alzheimer's disease pathogenesis.